Robert A. Hodgson

3.1k citations

42 papers · 1.8k indexed · 1 hit paper · h-index 21

Molecular Biology top 10%
Cellular and Molecular Neuroscience top 5%
Physiology top 10%
Neurology top 5%
Physiology top 1%

Co-authors: Geoffrey B. Varty Annamarie J. Pond Eric M. Parker Anjli Venkateswaran Judith Frydman Antti Nurmi Ron R. Kopito Alexander McCampbell
Topics: Receptor Mechanisms and Signaling (14 papers)Adenosine and Purinergic Signaling (9 papers)Neuroendocrine regulation and behavior (6 papers)
Cited by: Physiology Behavioral Neuroscience Cellular and Molecular Neuroscience
Journals: Neuroscience & Biobehavioral Reviews Journal of Neurochemistry Journal of Pharmacology and Experimental Therapeutics
Partner nations: United States Canada United Kingdom

In The Last Decade

Robert A. Hodgson

41 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Protein misfolding in neurodegenerative diseases: implications and strategies

2017 462 citations Anjli Venkateswaran, Robert A. Hodgson et al. profile →

Peers

Countries citing papers authored by Robert A. Hodgson

Since Specialization

Citations

This map shows the geographic impact of Robert A. Hodgson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Hodgson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Hodgson more than expected).

Fields of papers citing papers by Robert A. Hodgson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Hodgson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Hodgson. The network helps show where Robert A. Hodgson may publish in the future.

Co-authorship network of co-authors of Robert A. Hodgson

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Hodgson. A scholar is included among the top collaborators of Robert A. Hodgson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Hodgson. Robert A. Hodgson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aging: therapeutics for a healthy future 2019 ·Neuroscience & Biobehavioral Reviews ·Robert A. Hodgson,Brian K. Kennedy,Eliezer Masliah,Kimberly Scearce‐Levie,Barbara Tate,Anjli Venkateswaran,Steven P. Braithwaite	20
2	Discovery of aminoquinazoline derivatives as human A2A adenosine receptor antagonists 2015 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Robert Aslanian,(unknown),Tanweer A. Khan,Rongze Kuang,(unknown),Manuel de Lera Ruiz,Andrew W. Stamford,Pauline C. Ting,He‐Ping Wu,Hongwu Wang,Dong Xiao,(unknown),Yonglian Zhang,Deborra Mullins,Robert A. Hodgson	7
3	Characterization of a novel vasopressin V1b receptor antagonist, V1B-30N, in animal models of anxiety-like and depression-like behavior 2014 ·European Journal of Pharmacology ·Robert A. Hodgson,Deborra Mullins,Sherry Lu,M. Guzzi,Xiaoping Zhang,(unknown),Jack D. Scott,Michael W. Miller,Andrew W. Stamford,Eric M. Parker,Geoffrey B. Varty	25
4	Antagonism of the adenosine A2A receptor attenuates akathisia-like behavior induced with MP-10 or aripiprazole in a novel non-human primate model 2013 ·Pharmacology Biochemistry and Behavior ·(unknown),Tatiana M. Kazdoba,(unknown),John C. Hunter,Robert A. Hodgson	9
5	Quantitative Electroencephalography Within Sleep/Wake States Differentiates GABAA Modulators Eszopiclone and Zolpidem From Dual Orexin Receptor Antagonists in Rats 2013 ·Neuropsychopharmacology ·Steven V. Fox,Anthony L. Gotter,Spencer J. Tye,Susan L. Garson,Alan T. Savitz,Jason M. Uslaner,(unknown),Pamela L. Tannenbaum,Terrence P. McDonald,Robert A. Hodgson,Lihang Yao,Mark R. Bowlby,Scott D. Kuduk,Paul J. Coleman,Richard Hargreaves,Christopher J. Winrow,John J. Renger	33
6	A2A receptor antagonists do not induce dyskinesias in drug-naive or l-dopa sensitized rats 2013 ·Brain Research Bulletin ·Nicole M. Jones,(unknown),Deborra Mullins,Eric M. Parker,Robert A. Hodgson	20
7	The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia 2012 ·Bioorganic & Medicinal Chemistry Letters ·Ginny D. Ho,W. Michael Seganish,(unknown),Deen Tulshian,William J. Greenlee,(unknown),Alan Hruza,Li Xiao,Diane Rindgen,Deborra Mullins,M. Guzzi,Xiaoping Zhang,(unknown),Robert A. Hodgson	20
8	The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia 2011 ·Bioorganic & Medicinal Chemistry Letters ·Ginny D. Ho,Shu‐Wei Yang,(unknown),(unknown),Terry L. Nechuta,Elizabeth M. Smith,William T. McElroy,Zheng Tan,Deen Tulshian,Brian A. McKittrick,William J. Greenlee,Alan Hruza,Xiao Li,Diane Rindgen,Deborra Mullins,M. Guzzi,Xiaoping Zhang,(unknown),Robert A. Hodgson	28
9	Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders 2010 ·Experimental Neurology ·Robert A. Hodgson,Paul J. Bédard,Geoffrey B. Varty,Tatiana M. Kazdoba,Thérèse Di Paolo,(unknown),Annamarie J. Pond,(unknown),Nancy Bélanger,Laurent Grégoire,(unknown),Bernard R. Neustadt,Andrew W. Stamford,John C. Hunter	78
10	Characterization of the selective mGluR1 antagonist, JNJ16259685, in rodent models of movement and coordination 2010 ·Pharmacology Biochemistry and Behavior ·Robert A. Hodgson,Lynn A. Hyde,(unknown),Mary Cohen-Williams,Prescott T. Leach,Tatiana M. Kazdoba,(unknown),Sherry Lu,Eric M. Parker,Geoffrey B. Varty	13
11	JWE volume 4 issue 2 Cover and Front matter 2009 ·Journal of Wine Economics ·Kym Anderson,Orley Ashenfelter,Victor Ginsburgh,Robert N. Stavins,Karl Storchmann,(unknown),(unknown),Young Jae Lee,Brian P. Kennedy,(unknown),(unknown),(unknown),(unknown),(unknown),Robert A. Hodgson,Domenic V. Cicchetti,(unknown),(unknown)	1
12	Characterization of the Potent and Highly Selective A2A Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of Movement Disorders and Depression 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Robert A. Hodgson,Rosalia Bertorelli,Geoffrey B. Varty,Jean E. Lachowicz,A Forlani,Silva Fredduzzi,Mary Cohen-Williams,Guy A. Higgins,Francesco Impagnatiello,(unknown),Leonard E. Parra,Carolyn Foster,Ying Zhai,(unknown),Andrew W. Stamford,Eric M. Parker,Angelo Reggiani,John C. Hunter	128
13	Tetrahydroquinoline sulfonamides as vasopressin 1b receptor anatgonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·Jack D. Scott,Michael W. Miller,(unknown),Sue‐Ing Lin,Henry A. Vaccaro,(unknown),Deborra Mullins,M. Guzzi,Jay Weinstein,Robert A. Hodgson,Geoffrey B. Varty,Andrew W. Stamford,(unknown),Brian A. McKittrick,William J. Greenlee,Tony Priestley,Eric M. Parker	14
14	The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates 2008 ·Psychopharmacology ·Geoffrey B. Varty,Robert A. Hodgson,Annamarie J. Pond,(unknown),Eric M. Parker,John C. Hunter	40
15	The Anxiolytic-Like Effects of the Novel, Orally Active Nociceptin Opioid Receptor Agonist 8-[bis(2-Methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510) 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Geoffrey B. Varty,Sherry Lu,Cynthia A. Morgan,Mary Cohen-Williams,Robert A. Hodgson,April Smith‐Torhan,Hongtao Zhang,Ahmad Fawzi,Michael P. Graziano,Ginny D. Ho,Julius J. Matasi,Deen Tulshian,Vicki L. Coffin,Galen Carey	67
16	Characterization of the V1a antagonist, JNJ-17308616, in rodent models of anxiety-like behavior 2008 ·Psychopharmacology ·(unknown),Deborra Mullins,Cliona MacSweeney,Barbara Werner,Annamarie J. Pond,M. Guzzi,(unknown),Geoffrey B. Varty,Robert A. Hodgson	57
17	Duration of ultrasonic vocalizations in the isolated rat pup as a behavioral measure: Sensitivity to anxiolytic and antidepressant drugs 2007 ·Pharmacology Biochemistry and Behavior ·Robert A. Hodgson,David Guthrie,Geoffrey B. Varty	50
18	The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles 2005 ·Psychopharmacology ·Geoffrey B. Varty,Mariagrazia Grilli,A Forlani,Silva Fredduzzi,(unknown),(unknown),Robert A. Hodgson,Sherry Lu,(unknown),Annamarie J. Pond,Eric M. Parker,John C. Hunter,Guy A. Higgins,Angelo Reggiani,Rosalia Bertorelli	140
19	Training-induced and electrically induced potentiation in the neocortex 2004 ·Neurobiology of Learning and Memory ·Robert A. Hodgson,Zhanxin Ji,(unknown),(unknown),(unknown),R. Racine	53
20	Of Kiosks and Campuses 1995 ·T.H.E. Journal Technological Horizons in Education ·(unknown),Robert A. Hodgson	1

About Robert A. Hodgson

Robert A. Hodgson is a scholar working on Physiology, Behavioral Neuroscience and Biological Psychiatry, having authored 42 papers that have together received 1.8k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (14 papers), Adenosine and Purinergic Signaling (9 papers) and Neuroendocrine regulation and behavior (6 papers). The work is most often cited by research in Physiology (225 citations), Behavioral Neuroscience (170 citations) and Cellular and Molecular Neuroscience (586 citations). Robert A. Hodgson has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Geoffrey B. Varty, Annamarie J. Pond, Eric M. Parker, Anjli Venkateswaran, Judith Frydman, Antti Nurmi, Ron R. Kopito, Alexander McCampbell, Gabrielle G. Leblanc and Marc Baumann. Their work appears in journals such as Neuroscience & Biobehavioral Reviews, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact